Review



anti prdx2  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti prdx2
    Anti Prdx2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/10__3390_slash_biomedicines14030629-78-27-28
    Average 86 stars, based on 1 article reviews
    anti prdx2 - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Hypoxic conditioning rescues retinal precursor cells from CoCl2-induced ferroptosis via Drp1 and Vdac1
    Article Snippet: Background Traumatic optic neuropathy leads to irreversible vision loss due to ischemia and inflammation-induced apoptosis of optic-nerve axons.. Models of retinal ganglion cell and optic nerve degeneration involve induction by chemicals (cobalt chloride, LPS, and N-methyl-D-aspartate), mechanical stress (optic nerve compression, light), and ischemia (transient retinal ischemia).. Although exposure of R28 cells, retinal progenitor cells (RPCs), to severe hypoxia can cause cell damage and alter mitochondrial metabolism, the effects and mechanisms of hypoxia on these cells are unclear.

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals.
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKαThr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPKThr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKα Thr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPK Thr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2 Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..

    SDS Page:

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals.
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKαThr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPKThr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKα Thr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPK Thr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2 Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..

    Staining:

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals.
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKαThr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPKThr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKα Thr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPK Thr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2 Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..

    Blocking Assay:

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals.
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKαThr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPKThr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..

    Article Title: MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals
    Article Snippet: Protein concentrations from collected supernatants were determined via bicinchoninic acid (BCA) protein assay (Pierce, Rockform, IL, United States). .. Proteins (15 μg protein/well) were separated by either reducing or non-reducing SDS-PAGE on 4–15 % precast stain-free gels (Bio-Rad, Hercules, CA, United States) before being transferred onto PVDF membranes (Bio-Rad, 1704156) and incubated in blocking solution and primary antibody [Total OXPHOS Antibody Cocktail (Abcam ab110413, 1:1000), Catalase (Cell Signaling Technology 14097, 1:1000), PRDX2 (Cell Signaling Technology 46855, 1:1000), PRDX3 (Abcam ab73349, 1:1000), TRX1 (Cell Signaling Technology 2298, 1:1000), TRX2 (Cell Signalling Technology 14907, 1:1000), SOD1 (Cell Signaling Technology 2770, 1:1000), SOD2 (Cell Signaling Technology 13194, 1:1000), 4HNE (Abcam ab46545, 1:500), phospho-AMPKα Thr172 (Cell Signaling Technology 2535, 1:1000), AMPKα (Cell Signaling Technology 5831, 1:1000), phospho-p38 MAPK Thr180/Tyr182 (Cell Signaling Technology 4511, 1:1000), p38 MAPK (Cell Signaling Technology 8690, 1:1000), phospho-ERK1/2 Thr202/Tyr204 (Cell Signaling Technology 9101, 1:1000), ERK1/2 (Cell Signaling Technology 9102, 1:1000). ..



    Similar Products

    92
    MedChemExpress ucb exos
    Ucb Exos, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/Peroxiredoxin-2%2FPRDX2%2C+Human/pm42183902-89-17-28
    Average 92 stars, based on 1 article reviews
    ucb exos - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology prdx2 a 2 mouse monoclonal
    Prdx2 A 2 Mouse Monoclonal, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/PRX+II+Antibody/pm41932903-352-162-166
    Average 93 stars, based on 1 article reviews
    prdx2 a 2 mouse monoclonal - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti prdx2
    Anti Prdx2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/10__3390_slash_biomedicines14030629-78-27-28
    Average 86 stars, based on 1 article reviews
    anti prdx2 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory prdx2 knockout male mice
    Study design and overview Experimental design for time course metabolomic profiling of male C57Bl6 wild-type and <t>Prdx2−</t> mice in vivo labeling, Biotin+ and Biotin−bead separation. Blood draws were performed at three different time points (8, 15, and 20 days) for each cohort with targeted metabolomic profiling. The subsequent analyses enable assessment of biochemical aging in vivo and the consequences of loss of Prdx2.
    Prdx2 Knockout Male Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/knockout+male+mice+prdx2/pmc12859242-237-8-13
    Average 86 stars, based on 1 article reviews
    prdx2 knockout male mice - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology prdx2
    Study design and overview Experimental design for time course metabolomic profiling of male C57Bl6 wild-type and <t>Prdx2−</t> mice in vivo labeling, Biotin+ and Biotin−bead separation. Blood draws were performed at three different time points (8, 15, and 20 days) for each cohort with targeted metabolomic profiling. The subsequent analyses enable assessment of biochemical aging in vivo and the consequences of loss of Prdx2.
    Prdx2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/PRX+II+shRNA+Plasmid/pm41619511-41-8-20
    Average 94 stars, based on 1 article reviews
    prdx2 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    Proteintech prdx2
    Immunohistochemistry detected the protein expression of Peroxiredoxin1 (Prdx1) and <t>Prdx2</t> in brain tissues. (A) Prdx1 immunohistochemistry staining and expression levels in brain tissues; (B) Prdx2 immunohistochemistry staining and expression levels in brain tissues; ns, no significant difference, p > 0.05.
    Prdx2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/peroxiredoxin+2+Antibody/pmc12848523-94-34-35
    Average 93 stars, based on 1 article reviews
    prdx2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Proteintech anti prdx2
    Immunohistochemistry detected the protein expression of Peroxiredoxin1 (Prdx1) and <t>Prdx2</t> in brain tissues. (A) Prdx1 immunohistochemistry staining and expression levels in brain tissues; (B) Prdx2 immunohistochemistry staining and expression levels in brain tissues; ns, no significant difference, p > 0.05.
    Anti Prdx2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prdx2/peroxiredoxin+2+Antibody/pm41619511-72-11-5
    Average 93 stars, based on 1 article reviews
    anti prdx2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Study design and overview Experimental design for time course metabolomic profiling of male C57Bl6 wild-type and Prdx2− mice in vivo labeling, Biotin+ and Biotin−bead separation. Blood draws were performed at three different time points (8, 15, and 20 days) for each cohort with targeted metabolomic profiling. The subsequent analyses enable assessment of biochemical aging in vivo and the consequences of loss of Prdx2.

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Study design and overview Experimental design for time course metabolomic profiling of male C57Bl6 wild-type and Prdx2− mice in vivo labeling, Biotin+ and Biotin−bead separation. Blood draws were performed at three different time points (8, 15, and 20 days) for each cohort with targeted metabolomic profiling. The subsequent analyses enable assessment of biochemical aging in vivo and the consequences of loss of Prdx2.

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques: Metabolomic, In Vivo, Labeling

    Unsupervised analysis of intracellular metabolomic profiles Clustering of plasma metabolomics profiles for the entire set of cohorts. (A) Clustering of WT and Prdx2 KO profiles at days 8, 15, or 20. (B) Clustering of the PRdx2 KO/WT ratios at the different time points.

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Unsupervised analysis of intracellular metabolomic profiles Clustering of plasma metabolomics profiles for the entire set of cohorts. (A) Clustering of WT and Prdx2 KO profiles at days 8, 15, or 20. (B) Clustering of the PRdx2 KO/WT ratios at the different time points.

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques: Metabolomic, Clinical Proteomics

    Volcano plot comparisons between various pairwise experimental groups (A) Comparison of 3- versus 1-week-old RBCs showing similar trends for the WT and Prdx2 KO, particularly with increased ophthalmate and NaMN fold changes and decreased acyl-carnitines, alpha-ketoglutarate, and serotonin. There are notable metabolite differences in the Prdx2 KO mice RBCs that are also noted in other pairwise comparisons (e.g., uridine, inosine, tyrosine, and isoleucine). (B) Comparison of the youngest RBC cell population (day 8, Biotin−) versus the oldest, most heterogeneous RBC population (day 20, Biotin+). Very similar, concordant changes among metabolites are noted for the WT and Prdx2 KO alike. (C) Comparison of Prdx2 KO versus WT RBCs at 8, 15, and 20 days, respectively. These volcano plots highlight some of the genotypic differences in the in vivo aging study. Notable differences include increased intracellular fold changes in arginine, valine, and uridine. Although ophthalmate changes in Prdx2 KO and WT (A and B), quantitative response in the Prdx2 KO is different than the WT.

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Volcano plot comparisons between various pairwise experimental groups (A) Comparison of 3- versus 1-week-old RBCs showing similar trends for the WT and Prdx2 KO, particularly with increased ophthalmate and NaMN fold changes and decreased acyl-carnitines, alpha-ketoglutarate, and serotonin. There are notable metabolite differences in the Prdx2 KO mice RBCs that are also noted in other pairwise comparisons (e.g., uridine, inosine, tyrosine, and isoleucine). (B) Comparison of the youngest RBC cell population (day 8, Biotin−) versus the oldest, most heterogeneous RBC population (day 20, Biotin+). Very similar, concordant changes among metabolites are noted for the WT and Prdx2 KO alike. (C) Comparison of Prdx2 KO versus WT RBCs at 8, 15, and 20 days, respectively. These volcano plots highlight some of the genotypic differences in the in vivo aging study. Notable differences include increased intracellular fold changes in arginine, valine, and uridine. Although ophthalmate changes in Prdx2 KO and WT (A and B), quantitative response in the Prdx2 KO is different than the WT.

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques: Comparison, In Vivo

    Highlights of metabolite alterations in glycolysis Glycolysis and closely associated sugar metabolite sub-network with select bar charts of significantly altered metabolites for Old (day 20/Biotin+) and Young (day 8/Biotin−) for WT and Prdx2 KO mice. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Highlights of metabolite alterations in glycolysis Glycolysis and closely associated sugar metabolite sub-network with select bar charts of significantly altered metabolites for Old (day 20/Biotin+) and Young (day 8/Biotin−) for WT and Prdx2 KO mice. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques:

    Glutathione metabolism sub-network The glutathione sub-network with bar charts of select metabolites for Old (day 20/Biotin+) and Young (Day 8/Biotin−) for WT and Prdx2 KO mice. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Glutathione metabolism sub-network The glutathione sub-network with bar charts of select metabolites for Old (day 20/Biotin+) and Young (Day 8/Biotin−) for WT and Prdx2 KO mice. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques:

    NAD metabolism sub-network Outline of key steps in NAD metabolism with bar charts of select metabolites for Old (day 20/Biotin+) and Young (day 8/Biotin−) for WT and Prdx2 KO mice. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: NAD metabolism sub-network Outline of key steps in NAD metabolism with bar charts of select metabolites for Old (day 20/Biotin+) and Young (day 8/Biotin−) for WT and Prdx2 KO mice. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques:

    Highlights of metabolite alterations in fatty acid and glycerolipid metabolism Outline of the key steps in lipid metabolism with bar charts of select metabolites for Older (day 20/Biotin+) and Younger (day 8/Biotin−) RBC from WT and Prdx2 KO mice. There is more variability and noise in the lipid profiles. A notable exception is GPC, which exhibits among the largest and most significant alterations (consistent with prior work). Choline and carnitine are also notably altered. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Highlights of metabolite alterations in fatty acid and glycerolipid metabolism Outline of the key steps in lipid metabolism with bar charts of select metabolites for Older (day 20/Biotin+) and Younger (day 8/Biotin−) RBC from WT and Prdx2 KO mice. There is more variability and noise in the lipid profiles. A notable exception is GPC, which exhibits among the largest and most significant alterations (consistent with prior work). Choline and carnitine are also notably altered. Asterisks and associated bars demarcate significant differences (ANOVA, p < 0.05).

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques:

    Metabolomic alterations over time across all groups Four different, general time course trajectories (MI, MD, VI, and XI) have been observed over the entire metabolome, with either monotonic changes or concave versus trajectories with peaks versus nadirs, respectively, occurring at approximately 2 weeks of RBC age. Selected metabolites from different metabolic pathways encapsulating the various patterns of metabolite concentration shifts that occur over time in WT and Prdx2 KO RBC. Red dotted box: glutathione-related metabolites. Blue dotted box: glycolytic metabolites. The dark red and blue lines correspond to Biotin− RBC. The light red and blue lines correspond to Biotin+ RBC. Significant associations (ANOVA, p < 0.05) for same age comparisons (days 8, 15, and 20), respectively, are denoted by ∗ for WT Biotin+ vs. WT Biotin−, ‡ for Prdx2 KO Biotin+ vs. Prdx2 KO Biotin−, • for WT Biotin+ vs. Prdx2 KO Biotin−, and ∧ for WT Biotin− vs. Prdx2 KO Biotin−.

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Metabolomic alterations over time across all groups Four different, general time course trajectories (MI, MD, VI, and XI) have been observed over the entire metabolome, with either monotonic changes or concave versus trajectories with peaks versus nadirs, respectively, occurring at approximately 2 weeks of RBC age. Selected metabolites from different metabolic pathways encapsulating the various patterns of metabolite concentration shifts that occur over time in WT and Prdx2 KO RBC. Red dotted box: glutathione-related metabolites. Blue dotted box: glycolytic metabolites. The dark red and blue lines correspond to Biotin− RBC. The light red and blue lines correspond to Biotin+ RBC. Significant associations (ANOVA, p < 0.05) for same age comparisons (days 8, 15, and 20), respectively, are denoted by ∗ for WT Biotin+ vs. WT Biotin−, ‡ for Prdx2 KO Biotin+ vs. Prdx2 KO Biotin−, • for WT Biotin+ vs. Prdx2 KO Biotin−, and ∧ for WT Biotin− vs. Prdx2 KO Biotin−.

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques: Metabolomic, Concentration Assay

    Unsupervised analysis of mass action ratios (MARs) Linear discriminant analysis of the MAR in the RBC networks differentiates between the WT and Prdx2 KO as well as the homogeneous (Biotin−) and heterogeneous (Biotin+) aged RBCs.

    Journal: iScience

    Article Title: The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes

    doi: 10.1016/j.isci.2025.114608

    Figure Lengend Snippet: Unsupervised analysis of mass action ratios (MARs) Linear discriminant analysis of the MAR in the RBC networks differentiates between the WT and Prdx2 KO as well as the homogeneous (Biotin−) and heterogeneous (Biotin+) aged RBCs.

    Article Snippet: All animal experiments were performed with C57BL/6J or Prdx2 knockout male mice from The Jackson Laboratory (Bar Harbor, ME).

    Techniques:

    Immunohistochemistry detected the protein expression of Peroxiredoxin1 (Prdx1) and Prdx2 in brain tissues. (A) Prdx1 immunohistochemistry staining and expression levels in brain tissues; (B) Prdx2 immunohistochemistry staining and expression levels in brain tissues; ns, no significant difference, p > 0.05.

    Journal: Brain and Behavior

    Article Title: Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models

    doi: 10.1002/brb3.71231

    Figure Lengend Snippet: Immunohistochemistry detected the protein expression of Peroxiredoxin1 (Prdx1) and Prdx2 in brain tissues. (A) Prdx1 immunohistochemistry staining and expression levels in brain tissues; (B) Prdx2 immunohistochemistry staining and expression levels in brain tissues; ns, no significant difference, p > 0.05.

    Article Snippet: The membrane was blocked with 5% skim milk in TBST for 1 h at RT, followed by incubation with primary antibodies overnight at 4°C: GAPDH (Proteintech, No. 81640‐5‐RR, China), Prdx1 (Proteintech, No. 515816‐1‐AP, China), Prdx2 (Proteintech, No. 10545‐2‐AP, China), Prdx4 (ABonal, No. 4000001442, China).

    Techniques: Immunohistochemistry, Expressing, Staining

    RT‐qPCR detected the mRNA expression of Peroxiredoxin1 (Prdx1), Prdx2, Prdx4, and Prdx5 in brain tissues. (A) mRNA expression levels of Prdx1 in brain tissues; (B) mRNA expression levels of Prdx2 in brain tissues; (C) mRNA expression levels of Prdx4 in brain tissues; (D) mRNA expression levels of Prdx5 in brain tissues; * p < 0.05; ** p < 0.01.

    Journal: Brain and Behavior

    Article Title: Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models

    doi: 10.1002/brb3.71231

    Figure Lengend Snippet: RT‐qPCR detected the mRNA expression of Peroxiredoxin1 (Prdx1), Prdx2, Prdx4, and Prdx5 in brain tissues. (A) mRNA expression levels of Prdx1 in brain tissues; (B) mRNA expression levels of Prdx2 in brain tissues; (C) mRNA expression levels of Prdx4 in brain tissues; (D) mRNA expression levels of Prdx5 in brain tissues; * p < 0.05; ** p < 0.01.

    Article Snippet: The membrane was blocked with 5% skim milk in TBST for 1 h at RT, followed by incubation with primary antibodies overnight at 4°C: GAPDH (Proteintech, No. 81640‐5‐RR, China), Prdx1 (Proteintech, No. 515816‐1‐AP, China), Prdx2 (Proteintech, No. 10545‐2‐AP, China), Prdx4 (ABonal, No. 4000001442, China).

    Techniques: Quantitative RT-PCR, Expressing

    WB detected the protein expression of Peroxiredoxin1 (Prdx1), Prdx2, Prdx4, and Prdx5 in brain tissues. (A) Protein expression bands; (B) Prdx1 protein expression levels; (C) Prdx2 protein expression levels; (D) Prdx4 protein expression levels; (E) Prdx5 protein expression levels; ns, no significant difference, p > 0.05; * p < 0.05; ** p < 0.01.

    Journal: Brain and Behavior

    Article Title: Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models

    doi: 10.1002/brb3.71231

    Figure Lengend Snippet: WB detected the protein expression of Peroxiredoxin1 (Prdx1), Prdx2, Prdx4, and Prdx5 in brain tissues. (A) Protein expression bands; (B) Prdx1 protein expression levels; (C) Prdx2 protein expression levels; (D) Prdx4 protein expression levels; (E) Prdx5 protein expression levels; ns, no significant difference, p > 0.05; * p < 0.05; ** p < 0.01.

    Article Snippet: The membrane was blocked with 5% skim milk in TBST for 1 h at RT, followed by incubation with primary antibodies overnight at 4°C: GAPDH (Proteintech, No. 81640‐5‐RR, China), Prdx1 (Proteintech, No. 515816‐1‐AP, China), Prdx2 (Proteintech, No. 10545‐2‐AP, China), Prdx4 (ABonal, No. 4000001442, China).

    Techniques: Expressing

    The expression levels of Prdxs, reactive oxygen species (ROS), and nitric oxide (NO) in BV2 cells. (A) ROS fluorescence images; (B) ROS fluorescence levels in BV2 cells; (C) NO levels in BV2 cell supernatant; mRNA expression levels of Prdx1 (D), Prdx2 (E), Prdx4 (F), and Prdx5 (G) in BV2 cells; ns, no significant difference, p > 0.05; * p < 0.05; **** p < 0.0001.

    Journal: Brain and Behavior

    Article Title: Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models

    doi: 10.1002/brb3.71231

    Figure Lengend Snippet: The expression levels of Prdxs, reactive oxygen species (ROS), and nitric oxide (NO) in BV2 cells. (A) ROS fluorescence images; (B) ROS fluorescence levels in BV2 cells; (C) NO levels in BV2 cell supernatant; mRNA expression levels of Prdx1 (D), Prdx2 (E), Prdx4 (F), and Prdx5 (G) in BV2 cells; ns, no significant difference, p > 0.05; * p < 0.05; **** p < 0.0001.

    Article Snippet: The membrane was blocked with 5% skim milk in TBST for 1 h at RT, followed by incubation with primary antibodies overnight at 4°C: GAPDH (Proteintech, No. 81640‐5‐RR, China), Prdx1 (Proteintech, No. 515816‐1‐AP, China), Prdx2 (Proteintech, No. 10545‐2‐AP, China), Prdx4 (ABonal, No. 4000001442, China).

    Techniques: Expressing, Fluorescence

    WB detected the protein expression of Peroxiredoxin1 (Prdx1), Prdx2, Prdx4, and Prdx5 in BV2 cells. (A) Protein expression bands; protein expression levels of Prdx1 (B), Prdx2 (C), Prdx4 (D), and Prdx5 (E) in BV2 cells; ns, no significant difference, p > 0.05; * p < 0.05.

    Journal: Brain and Behavior

    Article Title: Lipopolysaccharide Upregulates Neuroinflammation, Oxidative Stress Responses, and Peroxiredoxins in Depression Models

    doi: 10.1002/brb3.71231

    Figure Lengend Snippet: WB detected the protein expression of Peroxiredoxin1 (Prdx1), Prdx2, Prdx4, and Prdx5 in BV2 cells. (A) Protein expression bands; protein expression levels of Prdx1 (B), Prdx2 (C), Prdx4 (D), and Prdx5 (E) in BV2 cells; ns, no significant difference, p > 0.05; * p < 0.05.

    Article Snippet: The membrane was blocked with 5% skim milk in TBST for 1 h at RT, followed by incubation with primary antibodies overnight at 4°C: GAPDH (Proteintech, No. 81640‐5‐RR, China), Prdx1 (Proteintech, No. 515816‐1‐AP, China), Prdx2 (Proteintech, No. 10545‐2‐AP, China), Prdx4 (ABonal, No. 4000001442, China).

    Techniques: Expressing